2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
13
Breast Neoplasms
13
Obesity
8
Motor Activity
7
Malnutrition
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Overweight
5
Weight Loss
4
Hypertension
4
Stroke
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Heart Failure
3
Diabetes Mellitus
3
Cardiovascular Diseases
3
Sarcopenia
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Osteoporosis
2
Kidney Diseases
2
Inflammation
2
Heart Diseases
2
Gastrointestinal Neoplasms
2
Frailty
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Registries
2
Methods
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
Telemedicine
1
Surveys and Questionnaires
1
Soybean Proteins
1
Risk Factors
1
Phlebotomy
1
Nutritional Status
1
Nutrition Assessment
1
Mycophenolic Acid
1
Imagery, Psychotherapy
1
Health Communication
1
Health
1
Fitness Trackers
1
FIBS
1
Exercise
1
Cyclosporine
1
Cause of Death
1
COVID-19 Vaccines
1
Busulfan
1
BNT162 Vaccine
1
Antilymphocyte Serum
1
Activities of Daily Living
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chronic Disease
×
Nutrition Assessment
×
Clear all
NCT04037436
2025-04-13
MoveStrong
University of Waterloo
Phase NA
Completed
44 enrolled
16 charts